Primary Care & Internal Medicine

General adult care, multimorbidity, and risk factor management at the front line.

  • 3 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.

Latest in Primary Care & Internal Medicine


ajmc.com > view > dallas-nephrology-associates-journey-to-value-based-care

Dallas Nephrology Associates’ Journey to Value-Based Care

44+ min ago   (747+ words) Population Health, Equity & Outcomes Preventing or delaying the onset of end-stage kidney disease is vital. By implementing a results-driven, value-based approach, Dallas Nephrology Associates has demonstrated improved patient outcomes and value for payers. Conclusions: By embracing value-based models, we have…...


ajmc.com > view > transforming-kidney-care-policy-risk-stratification-and-collaborative-models

Transforming Kidney Care: Policy, Risk Stratification, and Collaborative Models

44+ min ago   (414+ words) Population Health, Equity & Outcomes Experts at a recent Institute for Value-Based Medicine event emphasized the importance of early intervention, policy innovation, and proactive collaboration to transform the management of kidney disease and optimize patient outcomes. “To address CKD is to…...


bcm.edu > healthcare > specialties > spine-center > back-and-neck-conditions

Back and Neck Conditions

2+ hour, 11+ min ago   (269+ words) At the Baylor Medicine Spine Center, we treat varied and complex clinical problems associated with the spine. We treat all diseases of the cervical, thoracic and lumbar spine including: There are conditions that are not specific to any region of…...


cancernetwork.com > view > case-2-discussion-high-risk-cml-in-a-67-year-old-female

Case 2 Discussion: High-Risk CML in a 67-Year-Old Female

2+ hour, 12+ min ago   (254+ words) The panel discusses the case of a 67-year-old female patient diagnosed with high-risk chronic myelomonocytic leukemia (CML-1) who presents with intermediate risk scores and abnormal blood counts, including elevated white blood cells, mild thrombocytopenia, and anemia. The panel discusses the case…...


cancernetwork.com > view > defining-hma-failure-and-bridging-to-transplant-introduction-of-cml-case

Defining HMA Failure and Bridging to Transplant/Introduction of CML Case

2+ hour, 12+ min ago   (248+ words) This segment continues the discussion of high-risk MDS management, focusing on how clinicians define failure of HMAs and determine next steps in therapy, particularly in patients with TP53 mutations. This segment continues the discussion of high-risk MDS management, focusing on how…...


ajmc.com > view > identifying-myelodysplastic-syndromes-subtypes

Identifying Myelodysplastic Syndromes Subtypes

2+ hour, 13+ min ago   (235+ words) Expert perspectives on the changes in MDS subclassifications as understandings of the disease have evolved. Bruce Feinberg, DO: Amer, we’ve heard about it, and it’s clear that everyone involved—from the patient to the primary caregiver and the specialist and…...


ajmc.com > peer-exchange > oral-therapy-considerations-for-the-management-of-myelodysplastic-syndromes-mds-

Oral Therapy Considerations for the Management of Myelodysplastic Syndromes (MDS) | Peer Exchange | AJMC

2+ hour, 13+ min ago   (150+ words) A panel of experts discuss the complex nature of myelodysplastic syndromes and concurrent subclassifications. Shared insight on how to best educate patients and caregivers on the broad nature of myelodysplastic syndromes. Expert perspectives on the changes in MDS subclassifications as…...


ajmc.com > view > understanding-the-nature-of-myelodysplastic-syndromes

Understanding the Nature of Myelodysplastic Syndromes

2+ hour, 13+ min ago   (145+ words) A panel of experts discuss the complex nature of myelodysplastic syndromes and concurrent subclassifications. Bruce Feinberg, DO: When did we categorize MDS as a malignancy as opposed to a premalignant condition? When did that formally change? Bruce Feinberg, DO: As…...


fredhutch.org > en > news > spotlight > 2024 > 01 > tst-petersdorf-jclinicaloncology.html

HLA haplotype allelic variations can influence leukemia recurrence after blood stem cell transplantation

5+ hour, 38+ min ago   (590+ words) Through analyzing over 1,600 leukemia patients receiving hematopoietic cell transplants from haploidentical donors, the Petersdorf group identifies HLA haplotype allelic variations that influence risk of post-transplantation relapse. HLA haplotype allelic variations can influence leukemia recurrence after blood stem cell transplantation The…...


bioengineer.org > nearly-a-third-of-migrant-mothers-struggle-to-navigate-maternity-care-landmark-review-finds

Nearly a Third of Migrant Mothers Struggle to Navigate Maternity Care, Landmark Review Finds

31+ min ago   (640+ words) A systematic review of 81 studies finds migrant mothers in high-income countries face substantial barriers to understanding health information and accessing maternity care, with significantly higher odds of suboptimal antenatal care than non-migrant women....